Search

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

Steven Dube works with local, national and international developers, investors and lenders in the acquisition, financing, development and sale of real property throughout the Washington, D.C. metropolitan area. A significant portion of Steve's practice involves the structuring and documentation of...

Brandon Brauer's practice focuses primarily on commercial real estate transactions, including leases, purchases and sales, financings, construction contracts and condominium regime work. Brandon's experience includes single-asset and portfolio transactions with respect to multifamily properties...

Nicole E. Chammas concentrates her practice on commercial litigation, particularly insurance disputes. Her work representing insurers includes coverage-related disputes involving a wide variety of issues, including general liability, environmental, cyber, and professional liability policies. She...

Sarah Nichols is a member of the Transactional Department in the firm's Washington, D.C. office. She maintains a general corporate practice and assists with a variety of deals. While earning her J.D. at University of Richmond School of Law, Sarah was a legal innovation fellow for law firm, as well...

Geoffrey Langan advises clients on complex commercial real estate leasing and transactions and related litigation. His deep knowledge of the commercial real estate market is informed by his past work for more than a decade as in-house real estate counsel for the largest privately owned shopping...

Kevin M. Levy focuses primarily on real estate matters, including property sales and acquisitions, leases, commercial real estate lending and borrowing, development projects and real estate tax appeals. Kevin also advised clients on COVID-19 regulatory compliance and has commented extensively on...